Clinical trial monitoring supports phase III wet AMD trial

When a global pharmaceutical company and its CRO partner required assistance recruiting for a phase III trial investigating a wet AMD product, they made contact with Novotech in regards to including Australian sites in the global trial. 

The Background 

When a global pharmaceutical company and its CRO partner required assistance recruiting for a phase III trial investigating a wet AMD product, they made contact with Novotech in regards to including Australian sites in the global trial. 

Challenge 

As the product had been fasted tracked for TGA approval, clinical trial recruitment was welcomed by both Australian principal investigators and patients. 

Our Actions 

Novotech worked with one private and three public sites across Australia to help recruit patients for the trial, undertaking clinical trial monitoring across all sites. 

Results 

Following their positive experience with Novotech, the pharmaceutical company has since expanded its breadth of work with Novotech.